Bridgebio Pharma Inc (BBIO)

R&D Expenses

$149.45M

Quarterly · Period ending: · USD

BBIO logo

BBIO R&D Expenses

Latest reported$149.45M
BBIO Quarterly R&D Expenses ($33.83M → $149.45M)
High-resolution chart · PNG

BBIO r&d expenses history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Bridgebio Pharma Inc R&D Expenses — Quarterly (USD)
Period endingR&D Expenses (USD)
149,448,000
126,636,000
142,000,000
112,874,000
111,231,000
111,431,000
130,350,000
120,444,000
114,695,000
140,972,000
130,226,000
125,136,000
107,488,000
92,861,000
90,902,000
92,511,000
108,400,000
107,649,000
122,200,000
104,305,000
101,960,000
122,559,000
90,174,000
92,050,000
86,598,000
68,225,000
57,485,000
55,278,000
52,331,000
44,853,000
51,202,000
31,148,000
23,892,000
33,831,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.